These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24884749)

  • 41. Antibiotics: a shot in the arm.
    Leeb M
    Nature; 2004 Oct; 431(7011):892-3. PubMed ID: 15496888
    [No Abstract]   [Full Text] [Related]  

  • 42. China rushes through major funding system.
    Cyranoski D
    Nature; 2008 Sep; 455(7210):142. PubMed ID: 18784681
    [No Abstract]   [Full Text] [Related]  

  • 43. The $2.6 billion pill--methodologic and policy considerations.
    Avorn J
    N Engl J Med; 2015 May; 372(20):1877-9. PubMed ID: 25970049
    [No Abstract]   [Full Text] [Related]  

  • 44. Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.
    Burgess DS; Slain D; Mohr J; Wong-Beringer A; Destache C; Suda K
    Clin Infect Dis; 2010 Sep; 51(6):753; author reply 754-5. PubMed ID: 20731568
    [No Abstract]   [Full Text] [Related]  

  • 45. How can we improve access to new (and old) antibiotics in Australia?
    Cheng AC; Nation RL
    Med J Aust; 2013 Jul; 199(2):81-2. PubMed ID: 23879485
    [No Abstract]   [Full Text] [Related]  

  • 46. Government promises new steps to deal with antimicrobial resistance.
    O'Dowd A
    BMJ; 2014 Sep; 348():g5689. PubMed ID: 25233903
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug development: Time for teamwork.
    May M
    Nature; 2014 May; 509(7498):S4-5. PubMed ID: 24784427
    [No Abstract]   [Full Text] [Related]  

  • 48. Antibiotics at the crossroads.
    Nathan C
    Nature; 2004 Oct; 431(7011):899-902. PubMed ID: 15496893
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmaceutical research and development: what do we get for all that money?
    Light DW; Lexchin JR
    BMJ; 2012 Aug; 345():e4348. PubMed ID: 22872694
    [No Abstract]   [Full Text] [Related]  

  • 50. US drug manufacturers set up joint testing group.
    Davies E
    BMJ; 2012 Sep; 345():e6394. PubMed ID: 23002149
    [No Abstract]   [Full Text] [Related]  

  • 51. Of silver bullets and red herrings: invited commentary to Fisk et al.
    Razum O; Schaaber J; Nayar KR
    Trop Med Int Health; 2011 Jun; 16(6):669-71. PubMed ID: 21501348
    [No Abstract]   [Full Text] [Related]  

  • 52. Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals.
    Kesselheim AS; Outterson K
    Health Aff (Millwood); 2010 Sep; 29(9):1689-96. PubMed ID: 20820028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Advantages and disadvantages of an antibiotic policy].
    López-Brea M; Domingo D
    Enferm Infecc Microbiol Clin; 1998 Oct; 16(8):353-5. PubMed ID: 9835148
    [No Abstract]   [Full Text] [Related]  

  • 54. [National antibiotic stewardship policy: advocating a new strategy].
    Roger PM; Blanc V; Keita-Perse O; Lieutier-Colas F
    Med Mal Infect; 2014 Dec; 44(11-12):489-90. PubMed ID: 25455076
    [No Abstract]   [Full Text] [Related]  

  • 55. A framework for the non-antibiotic management of upper respiratory tract infections: towards a global change in antibiotic resistance.
    Essack S; Pignatari AC
    Int J Clin Pract Suppl; 2013 Nov; (180):4-9. PubMed ID: 24238424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Budget cuts and the plight of postdocs.
    Goozner M
    J Natl Cancer Inst; 2013 Feb; 105(3):153-4. PubMed ID: 23334223
    [No Abstract]   [Full Text] [Related]  

  • 57. Stemming the tide? Advances in antibiotic discovery and development in the face of emerging resistance and financial constraint.
    Page MG; Kellenberger L
    Curr Opin Pharmacol; 2012 Oct; 12(5):519-21. PubMed ID: 22884906
    [No Abstract]   [Full Text] [Related]  

  • 58. The Global Innovation Model for Antibiotics Needs Reinvention.
    Balasegaram M; Clift C; Røttingen JA
    J Law Med Ethics; 2015; 43 Suppl 3():22-6. PubMed ID: 26243239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotic discovery in the twenty-first century: current trends and future perspectives.
    Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
    J Antibiot (Tokyo); 2010 Aug; 63(8):423-30. PubMed ID: 20551985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Report urges controversial 'delinkage' to foster new antibiotics.
    Holmes D
    Nat Med; 2014 Apr; 20(4):320. PubMed ID: 24710363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.